Whey Proteins
Conditions
Interventions
This pilot study will be conducted as a randomized, controlled, double-blind experimental clinical trial, with a 1:1 allocation ratio. It will investigate the effects of two interventions on strength
Buriti Group (n = 20): Participants will receive buriti-based hyperprotein supplementation (Mauritia flexuosa), containing 70% protein and micronutrients derived from buriti, also divided into men (n
G11.427.410.698.277
Sponsors
Universidade Estadual de Montes Claros
Universidade Estadual de Montes Claros
Eligibility
Age
18 Years to 35 Years
Inclusion criteria
Inclusion criteria: The study will enroll men and women; aged between 18 and 35 years; who are apparently healthy according to the criteria of the Physical Activity Readiness Questionnaire for Everyone (PAR-Q+); and classified as insufficiently active or sedentary based on the International Physical Activity Questionnaire (IPAQ)
Exclusion criteria
Exclusion criteria: Individuals with musculoskeletal injuries that limit the capacity for moderate and vigorous exercise during the study period; neoplastic, hepatic, renal, or cardiovascular disorders; malabsorption disorders; those consuming anti-inflammatory drugs, analgesics, antibiotics, or vitamin and mineral supplements during the study period; individuals on medications affecting metabolic profile; and vegetarians will be excluded. Additional exclusion criteria will include pregnancy and breastfeeding
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Anthropometric parameters and body composition: an improvement in body composition, such as fat mass and lean mass, as well as changes in anthropometric parameters, is expected to be observed through the measurement of skinfolds, body circumferences, and assessed using a tetrapolar bioimpedance device one week before and after the intervention;Strength gain: an improvement in muscle strength is expected, evaluated using different dynamometers one week before and after the intervention;Hemodynamic parameters: a reduction in blood pressure levels is expected, evaluated through the measurement of blood pressure (mmHg) according to the recommendations of the Brazilian Society of Cardiology, conducted one week before and after the intervention;Rectus femoris muscle: changes in the cross-sectional area of the muscle are expected to be observed, measured using ultrasound one week before and after the intervention;Biochemical parameters: changes in biochemical parameters, such as glucose levels, lipid profile, inflammatory markers, and hormonal levels, are expected to be observed, evaluated through blood tests conducted one week before and after the intervention | — |
Secondary
| Measure | Time frame |
|---|---|
| Quality of life and emotional aspects: changes in anxiety levels, risk of depression, sleep quality, and quality of life are expected to be observed, evaluated through validated questionnaires for the Brazilian population administered one week before and after the intervention | — |
Countries
Brazil
Contacts
Public ContactSérgio Santos
Universidade Estadual de Montes Claros
Outcome results
None listed